Skip to content
drillr.ai
Sign up

BBOT

BridgeBio Oncology Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.64
−2.37%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-67.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 23, 2026Cobo Marc · officer: Principal Accounting OfficerF-InKind203$2.68
Oct 5, 2026Cobo Marc · officer: Principal Accounting OfficerF-InKind126$3.94
Oct 5, 2026Ben Yong · officer: Chief Med & Dev OfficerF-InKind1,047$3.94
Oct 5, 2026Beltran Pedro · director, officer: President and CEOF-InKind1,047$3.94
Oct 5, 2026Elmelech Idan · officer: COO & Principal Financial OfcrF-InKind343$3.94
Sep 14, 2026Cobo Marc · officer: Principal Accounting OfficerF-InKind203$5.52
Sep 14, 2026Cobo Marc · officer: Principal Accounting OfficerA-Award43,700$5.52
Sep 14, 2026Cobo Marc · officer: Principal Accounting OfficerA-Award9,038$0.00
Jul 6, 2026Elmelech Idan · officer: COO & Principal Financial OfcrF-InKind343$7.80
Jul 6, 2026Beltran Pedro · director, officer: President and CEOF-InKind1,047$7.80
Jul 6, 2026Ben Yong · officer: Chief Med & Dev OfficerF-InKind1,047$7.80
Jul 6, 2026Cobo Marc · officer: Principal Accounting OfficerF-InKind125$7.80
Jun 18, 2026MCCORMICK FRANK · directorA-Award31,675$7.73
Jun 18, 2026Kumar Neil · directorA-Award31,675$7.73
Jun 18, 2026Bauer Jake · directorA-Award31,675$7.73
Jun 18, 2026Chen Bihua · director, 10 percent owner: A-Award31,675$7.73
Jun 18, 2026Kelleher Raymond J. · directorA-Award31,675$7.73
Jun 18, 2026Lebowitz Peter F · directorA-Award7,289$7.73
Jun 18, 2026Tipirneni Praveen P. · directorA-Award31,675$7.73
May 12, 2026Beltran Pedro · director, officer: President and CEOA-Award1,103,837$7.66
May 12, 2026Elmelech Idan · officer: COO & Principal Financial OfcrA-Award758,222$7.66
May 5, 2026Beltran Pedro · director, officer: President and CEOF-InKind1,047$9.03
May 5, 2026Mehra Uneek · other: Former OfficerF-InKind524$9.03
May 5, 2026Ben Yong · officer: Chief Med & Dev OfficerF-InKind1,047$9.03
Mar 26, 2026Lebowitz Peter F · directorA-Award63,350$8.72
Mar 12, 2026Beltran Pedro · officer: Chief Scientific OfficerA-Award210,000$10
Mar 12, 2026Ben Yong · officer: Chief Med & Dev OfficerA-Award210,000$10
Mar 12, 2026Ben Yong · officer: Chief Med & Dev OfficerA-Award46,670$0.00
Mar 12, 2026Mehra Uneek · officer: Chief Financial OfficerA-Award23,330$0.00
Mar 12, 2026Beltran Pedro · officer: Chief Scientific OfficerA-Award46,670$0.00
Institutional positioning

13F filings over the trailing two quarters

New 41Increased 39Reduced 28Sold out 21
FilerActionSharesFiled
CORMORANT ASSET MANAGEMENT, LPUnchanged17,878,594May 15, 2026
Cormorant Asset Management, LPUnchanged17,878,594Aug 14, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.Unchanged4,885,446Aug 14, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Unchanged4,885,446May 15, 2026
Omega Fund Management, LLCUnchanged3,289,661Aug 14, 2026
OMEGA FUND MANAGEMENT, LLCUnchanged3,289,661May 15, 2026
Alphabet Inc.Unchanged2,823,126Aug 7, 2026
ECOR1 CAPITAL, LLCUnchanged2,823,126May 15, 2026
EcoR1 Capital, LLCUnchanged2,823,126Aug 14, 2026
ALPHABET INC.Unchanged2,823,126May 8, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced2,818,348May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced2,789,302Aug 14, 2026
ENAVATE SCIENCES GP, LLCUnchanged2,626,946May 15, 2026
Enavate Sciences GP, LLCUnchanged2,626,946Aug 14, 2026
CITADEL ADVISORS LLCIncreased2,617,827Sep 2, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 23, 2026